EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

L-TPS17 - Allergen immunotherapy 07

Sunday 15 Jun, 12:45 PM - 13:45 PM Glasgow, United Kingdom
10:45 AM - 11:45 AM Your local time
Poster Zone Thematic Poster Session
A new allergenic protein in holm oak (Quercus ilex) pollen: Glutathione-S-transferase
Adverse reactions to subcutaneous immunotherapy for mite in children and adolescents in a tertiary care center
Adverse reactions to sublingual immunotherapy with carbamylated allergoids of different sources in clinical studies
Case report: Acute systemic reactions to sublingual immunotherapy for tree pollen
Comparison of Completion Rates and Factors Influencing Discontinuation in Paediatric Allergen Immunotherapy: A Five-Year Single-Center Experience
Efficacy of Index of reactivity (IR) liquid sublingual immunotherapy in allergic rhinoconjunctivitis: A systematic review and meta-analysis of randomised studies
Follow up cases of subcutaneous allergen Immunotherapy in respiratory allergic diseases continuing for 10-30years “A Real life experience of 14 cases”
Good patient adherence to sublingual immunotherapy for allergic rhinitis can be achieved, when ENT-physicians collaborate with pharmacies in a straightforward adherence programme
Health Economic Evaluation of 5-Grass Pollen Sublingual ImmunotherapyTablets for Grass Pollen-Induced Allergic Rhinitis in Finland, Norway and Sweden
Reduction in Healthcare Resource Utilization in patients treated with 300 IR liquid SLIT: Real-World Evidence from Spain and Italy
Safety of 300IR liquid sublingual immunotherapy of cat allergen extract for respiratory allergy to cat dander: a post-marketing experience
The 300 IR house dust mite sublingual tablet is effective and well tolerated in patients with allergic rhinoconjunctivitis and concomitant allergic asthma in a real-world data setting
Treatment with the 300 IR house dust mite sublingual tablet is safe and well tolerated in adults and adolescents in a real-world data setting – results of a non-interventional post authorization safety study

Speakers